Department of Anesthesiology, Mayo Clinic, Jacksonville, Florida, USA.
Department of Neurologic Surgery, Mayo Clinic, Jacksonville, Florida, USA; Department of Surgery, University of California, San Diego, California, USA.
World Neurosurg. 2021 Jun;150:e31-e37. doi: 10.1016/j.wneu.2021.02.009. Epub 2021 Mar 5.
This study compares the postsurgical course of frontotemporal craniotomies conducted "awake" under regional anesthesia (RA) versus "asleep" under general anesthesia (GA) to investigate postoperative recovery, pain, opioid use, and anesthesia-related side effects.
We retrospectively reviewed craniotomies for supratentorial, intra-axial tumors with frontotemporal exposure. Chronic opioid use and emergent cases were excluded. Primary outcomes included pain scores on a 0-10 numerical rating scale, opioid use as oral morphine milligram equivalence, first time to opioid use, nausea, and sedation on the Richmond Agitation and Sedation Scale (RASS). Secondary outcomes included postoperative seizures, Karnofsky Performance Scale (KPS) status, and hospital length of stay (LOS).
A total of 91 patients met inclusion criteria: 56 underwent a craniotomy under RA versus 35 under GA. Demographics and operative characteristics were similar between cohorts. A significant reduction in both postoperative pain and opioid use was observed among RA versus GA (first postoperative pain score 2 vs. 5, P < 0.01; postoperative day [POD] 0 median pain score 2.5 vs. 4, P < 0.01; POD 0 mean opioid in mg 14.49 vs. 24.43, P < 0.01). The time until patients requested opioids for pain after surgery was prolonged for RA versus GA [mean 7.23 vs. 3.42 hours, P < 0.01). Somnolence (RASS < 0) on POD 0 was significantly reduced among RA versus GA, with 23% versus 43%. Both cohorts had equivocal postsurgical outcomes such as seizures, KPS, and hospital LOS.
Frontotemporal craniotomy under RA during awake craniotomies provides better pain control, a reduction in opioid use, and less somnolence in the early postoperative period.
本研究比较了在区域麻醉(RA)下“清醒”进行的额颞部开颅术与在全身麻醉(GA)下“入睡”进行的额颞部开颅术的术后过程,以研究术后恢复、疼痛、阿片类药物使用和与麻醉相关的副作用。
我们回顾性分析了额颞部暴露的幕上、脑内轴内肿瘤的开颅术。排除慢性阿片类药物使用者和急诊病例。主要结局包括 0-10 数字评分量表上的疼痛评分、口服吗啡毫克等效物的阿片类药物使用、首次使用阿片类药物的时间、恶心和 Richmond 激越和镇静量表(RASS)上的镇静。次要结局包括术后癫痫发作、卡诺夫斯基表现量表(KPS)状态和住院时间(LOS)。
共有 91 例患者符合纳入标准:56 例行 RA 下开颅术,35 例行 GA 下开颅术。两组患者的人口统计学和手术特征相似。与 GA 相比,RA 显著降低了术后疼痛和阿片类药物使用(术后第 1 天疼痛评分 2 分 vs. 5 分,P < 0.01;术后第 0 天中位数疼痛评分 2.5 分 vs. 4 分,P < 0.01;术后第 0 天平均阿片类药物用量 14.49 毫克 vs. 24.43 毫克,P < 0.01)。RA 组要求术后止痛的时间明显长于 GA 组[平均 7.23 小时 vs. 3.42 小时,P < 0.01]。与 GA 相比,RA 组术后第 0 天的嗜睡(RASS < 0)显著减少,分别为 23%和 43%。两组的术后结果如癫痫发作、KPS 和住院 LOS 均相似。
在清醒开颅术中进行额颞部 RA 可提供更好的疼痛控制、减少阿片类药物使用和减少术后早期的嗜睡。